Walgreens Boots Alliance, Inc. - Common Stock (WBA)
11.47
-0.02 (-0.17%)
NASDAQ · Last Trade: Jul 4th, 12:29 AM EDT
Detailed Quote
Previous Close
11.49
Open
11.45
Bid
11.45
Ask
11.48
Day's Range
11.43 - 11.49
52 Week Range
8.080 - 13.25
Volume
6,656,777
Market Cap
-
PE Ratio (TTM)
-
EPS (TTM)
-
Dividend & Yield
1.000 (8.72%)
1 Month Average Volume
6,986,567
Chart
About Walgreens Boots Alliance, Inc. - Common Stock (WBA)
Walgreens Boots Alliance is a global healthcare leader that operates a chain of pharmacies, drugstores, and health and wellness retail outlets. The company is known for providing accessible pharmaceutical services and a wide range of health and beauty products. With a commitment to enhancing the health and well-being of its customers, Walgreens Boots Alliance focuses on delivering innovative healthcare solutions, including pharmacy services, immunizations, and health consultations. Additionally, the company engages in retail pharmacy and wholesale distribution, partnering with various healthcare providers to improve patient outcomes and ensure the availability of essential medications and healthcare products. Read More
Synergy CHC Corp. (NASDAQ: SNYR) has surged over 74% in the last 30 days, fueled by the execution of a sweeping retail expansion strategy for its flagship FOCUSfactor® brand, now available in both supplement and functional beverage form. The brand’s rollout to over 50,000 locations —via Core-Mark, Walmart Canada, Metro Ontario, and Downey Wholesale—marks a major milestone, unlocking national reach across mass retail, grocery, convenience, and independent channels.
The global transdermal patch market is quietly gaining ground. Valued at $7.8 billion in 2023, it is projected to reach nearly $10.95 billion by 2030. Within that, pain patches are leading the way, expected to grow from $4.8 billion in 2021 to $7.3 billion by 2031.
The Boulder Group, a net leased investment brokerage firm, completed the sale of a single tenant net leased Chase Bank property located at 3600 Bardstown Road in Louisville, Kentucky for $3,700,000.
Synergy CHC Corp. (NASDAQ: SNYR), a rising consumer staple health company, has announced a wave of major expansion throughout North American for its FOCUSfactor® supplements and functional beverage brands, across mass, grocery, convenience, and wholesale channels. Functional Beverage Momentum
The case stems from a whistleblower lawsuit filed by a former Aetna actuary who alleged CVS Caremark manipulated drug pricing to inflate Medicare claims while underpaying pharmacies.
Wall Street entered full rally mode on Thursday, with the Nasdaq 100 extending its record-setting climb and the S&P 500 approaching its February peak, as easing geopolitical fears and renewed hopes for a dovish Federal Reserve lifted investor sentiment.
Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.2% year on year to $38.99 billion. Its non-GAAP profit of $0.38 per share was 11.3% above analysts’ consensus estimates.
Micron Technology’s artificial intelligence-powered third-quarter outperformance could be a welcome relief to traders who are left to contend with macro and geopolitical challenges.
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on.
But the flip side is that these businesses have increased downside risk because they lack the scale and staying power of their larger competitors.
